Table 2.

Obstetrics Outcomes.

HRT hCG LH Surge P Value
Ongoing pregnancies, n 78 54 40
Live birth rate, n 93 68 50
Singleton ongoing pregnancies, % (n) 84.6 (66) 83.3 (45) 75.0 (30) NS
Vaginal delivery, % (n) 66.6 (42/63) 66.7 (30/45) 53.3 (16/30) NS
Cesarean section, % (n) 33.3 (21/63) 33.3 (15/45) 46.6 (14/30) NS
Gestational age, mean±SD 38.3±2.8 38.4±3.1 39.0±3.5 NS
Fetal weight, mean±SD 3254.6±652.2 3236.1±647.3 3219.4±524.6 NS
Fetal length, mean±SD 51.2±2.6 49.8±3.1 51.5±2.1 NS
Twin ongoing pregnancies, % (n) 15.3 (12/78) 16.6 (9/54) 25 (10/40) NS
Vaginal delivery, % (n) 13.3 (2/12) 33.3 (3/9) 10.0 (1/10) NS
Cesarean section, % (n) 83.3 (10/12) 66.6 (6/9) 90.0 (9/10) NS
Gestational age, mean±SD 34.3±2.6 34.6±2.9 35.6±2.6 NS
Fetal weight, g, mean±SD 1966.2±292.3 2050.9±325.5 2096.3±358.1 NS
Fetal length, cm, mean±SD 46.3±2.1 49.2±2.6 45.8±2.5 NS

hCG, human chorionic gonadotropin; HRT, hormone replacement therapy; LH, luteinizing hormone; NS, not significant.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2017 April; 8(2): e0020. ISSN: 2076-9172
Published online 2017 April 28. doi: 10.5041/RMMJ.10297